76 related articles for article (PubMed ID: 2168429)
1. Clinical application of somatostatin receptor imaging.
Reichlin S
J Clin Endocrinol Metab; 1990 Sep; 71(3):564-5. PubMed ID: 2168429
[No Abstract] [Full Text] [Related]
2. Receptors on tumors studied with radionuclide scintigraphy.
Larson S
J Nucl Med; 1991 Jun; 32(6):1189-91. PubMed ID: 1646303
[No Abstract] [Full Text] [Related]
3. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.
Bakker WH; Krenning EP; Breeman WA; Koper JW; Kooij PP; Reubi JC; Klijn JG; Visser TJ; Docter R; Lamberts SW
J Nucl Med; 1990 Sep; 31(9):1501-9. PubMed ID: 1975618
[TBL] [Abstract][Full Text] [Related]
4. [Significance of somatostatin receptors for diagnosis and therapy of endocrine pancreatic tumors].
Schusdziarra V
Z Gastroenterol; 1991 Jul; 29(7):363-4. PubMed ID: 1659049
[No Abstract] [Full Text] [Related]
5. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
[No Abstract] [Full Text] [Related]
7. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
[No Abstract] [Full Text] [Related]
8. In vivo somatostatin receptor imaging in the detection and treatment of gastrointestinal cancer.
Schubert ML
Gastroenterology; 1991 Apr; 100(4):1143-4. PubMed ID: 1848196
[No Abstract] [Full Text] [Related]
9. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man.
Bakker WH; Krenning EP; Breeman WA; Kooij PP; Reubi JC; Koper JW; de Jong M; Laméris JS; Visser TJ; Lamberts SW
J Nucl Med; 1991 Jun; 32(6):1184-9. PubMed ID: 1646302
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
Metabolism; 1990 Sep; 39(9 Suppl 2):152-5. PubMed ID: 2169572
[TBL] [Abstract][Full Text] [Related]
11. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
[TBL] [Abstract][Full Text] [Related]
13. [Receptor scintigraphy with somatostatin analog in oncology].
Krenning EP; Bakker WH; Lamberts SW
Ned Tijdschr Geneeskd; 1990 Jun; 134(22):1077-80. PubMed ID: 1972265
[No Abstract] [Full Text] [Related]
14. Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy.
Reubi JC
Q J Nucl Med; 1997 Jun; 41(2):63-70. PubMed ID: 9203845
[TBL] [Abstract][Full Text] [Related]
15. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.
Krenning EP; Bakker WH; Breeman WA; Koper JW; Kooij PP; Ausema L; Lameris JS; Reubi JC; Lamberts SW
Lancet; 1989 Feb; 1(8632):242-4. PubMed ID: 2563413
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin-receptor imaging for the detection of tumors.
Patel YC
N Engl J Med; 1990 Nov; 323(18):1274-6. PubMed ID: 2170841
[No Abstract] [Full Text] [Related]
17. Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
Lamberts SW; Reubi JC; Bakker WH; Krenning EP
Z Gastroenterol; 1990 Sep; 28 Suppl 2():20-1. PubMed ID: 1980773
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
Krenning EP; Kwekkeboom DJ; Oei HY; Reubi JC; van Hagen PM; Kooij PP; Reijs AE; Lamberts SW
Schweiz Med Wochenschr; 1992 Apr; 122(17):634-7. PubMed ID: 1350377
[TBL] [Abstract][Full Text] [Related]
19. Influence of isotope dose on somatostatin receptor imaging: when less is better.
Schirmer TP; O'Dorisio TM; Olsen JO; Hinkle GH; O'Dorisio MS; Schirmer WJ
Semin Oncol; 1994 Oct; 21(5 Suppl 13):51-5. PubMed ID: 7992082
[No Abstract] [Full Text] [Related]
20. [A new imaging procedure for detecting endocrine tumors].
Schäffer M; Fölsch UR
Z Gastroenterol; 1991 Apr; 29(4):173-4. PubMed ID: 1651031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
